Avalo Therapeutics AVTX Total debt

Total debt at other companies

Eli LillyLLY

$54.91B+37.6%

AbbVieABBV

$62.36B+1.8%

Aclaris TherapeuticsACRS

$1.85M-21.8%

Shattuck Labs, Inc.STTK

$2.89M-9.5%

AnaptysBio, Inc.ANAB

$13.61K-99.9%

AbCellera Biologics Inc.ABCL

$135.62M-4.5%

FAQ

What is Avalo Therapeutics's total debt?

Avalo Therapeutics (AVTX) reported total debt of $242K in Q2 2026.

How has Avalo Therapeutics's total debt changed year-over-year?

Avalo Therapeutics's total debt decreased by 64.4% year-over-year, from $679K to $242K.

What is the long-term trend for Avalo Therapeutics's total debt?

Over 5 years (2020 to 2025), Avalo Therapeutics's total debt has grown at a -21.8% compound annual growth rate (CAGR), from $1.46M to $427K.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.